Literature DB >> 22401792

Modeling an integrative oncology program within a community-centered oncology service in Israel.

Eran Ben-Arye1, Elad Schiff, Chen Shapira, Moshe Frenkel, Tamar Shalom, Mariana Steiner.   

Abstract

OBJECTIVE: Describing the processes that preceded the opening of an integrative oncology program (IOP) within the oncology service (OS) of the largest health maintenance organization in northern Israel.
METHODS: The groundwork towards initiation of the IOP was based on three key elements (1) Interviews with patients, practitioners and directors were performed in order to explore perspectives regarding complementary medicine integration (CM) within the OS; (2) review of research data on CM efficacy and safety in cancer care; (3) critical comparative analysis of seven models of IOPs in Israel, Europe, and the U.S.
RESULTS: Ninety-three interviews included 24 patients, 34 conventional practitioners, 9 medical directors, and 26 CM-trained practitioners. The interviews revealed that there is a need for CM in the OS, aimed towards improving patients' well-being during chemotherapy and advanced disease. An integrative oncology score (IOS) was formulated based on 6 themes considered promoters of successful integration.
CONCLUSIONS: Integration of CM within an oncology service should address patients' needs and research knowledge and be built upon mandatory practitioners' communication. PRACTICE IMPLICATIONS: IOP modeling necessitates in-depth study aimed at revealing the OS needs and expectations, adjusting research data to the OS clinical challenges, and tailoring an appropriate model of integrative care.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22401792     DOI: 10.1016/j.pec.2012.02.011

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  19 in total

1.  Inverse relationship between reduced fatigue and severity of anemia in oncology patients treated with integrative medicine: understanding the paradox.

Authors:  Eran Ben-Arye; Ofer Dahan; Ilanit Shalom-Sharabi; Noah Samuels
Journal:  Support Care Cancer       Date:  2018-06-07       Impact factor: 3.603

2.  Assessing patient adherence to a complementary medicine treatment regimen in an integrative supportive care setting.

Authors:  Eran Ben-Arye; Dikla Kruger; Noah Samuels; Lital Keinan-Boker; Tamar Shalom; Elad Schiff
Journal:  Support Care Cancer       Date:  2014-03       Impact factor: 3.603

3.  Quality of life-related outcomes from a patient-tailored integrative medicine program: experience of Russian-speaking patients with cancer in Israel.

Authors:  Ilanit Shalom Sharabi; Anna Levin; Elad Schiff; Noah Samuels; Olga Agour; Yehudith Tapiro; Efraim Lev; Lital Keinan-Boker; Eran Ben-Arye
Journal:  Support Care Cancer       Date:  2016-05-11       Impact factor: 3.603

4.  Integration of complementary medicine in supportive cancer care: survey of health-care providers' perspectives from 16 countries in the Middle East.

Authors:  Eran Ben-Arye; Elad Schiff; Kamer Mutafoglu; Suha Omran; Ramzi Hajjar; Haris Charalambous; Tahani Dweikat; Ibtisam Ghrayeb; Gil Bar Sela; Ibrahim Turker; Azza Hassan; Esmat Hassan; Ariela Popper-Giveon; Bashar Saad; Omar Nimri; Rejin Kebudi; Jamal Dagash; Michael Silbermann
Journal:  Support Care Cancer       Date:  2015-01-24       Impact factor: 3.603

Review 5.  Integrating complementary medicine in supportive cancer care models across four continents.

Authors:  Eran Ben-Arye; Elad Schiff; Catherine Zollman; Peter Heusser; Pablo Mountford; Moshe Frenkel; Gil Bar-Sela; Ofer Lavie
Journal:  Med Oncol       Date:  2013-02-23       Impact factor: 3.064

6.  Quality-of-life outcomes in patients with gynecologic cancer referred to integrative oncology treatment during chemotherapy.

Authors:  Eran Ben-Arye; Noah Samuels; Elad Schiff; Orit Gressel Raz; Ilanit Shalom Sharabi; Ofer Lavie
Journal:  Support Care Cancer       Date:  2015-03-10       Impact factor: 3.603

7.  Can complementary medicine increase adherence to chemotherapy dosing protocol? A controlled study in an integrative oncology setting.

Authors:  Ilanit Shalom-Sharabi; Ofer Lavie; Noah Samuels; Lital Keinan-Boker; Efraim Lev; Eran Ben-Arye
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-20       Impact factor: 4.553

8.  Effect of a patient-tailored integrative medicine program on gastro-intestinal concerns and quality of life in patients with breast and gynecologic cancer.

Authors:  Ilanit Shalom-Sharabi; Noah Samuels; Ofer Lavie; Efraim Lev; Lital Keinan-Boker; Elad Schiff; Eran Ben-Arye
Journal:  J Cancer Res Clin Oncol       Date:  2017-02-28       Impact factor: 4.553

9.  Bridging cross-cultural gaps: monitoring herbal use during chemotherapy in patients referred to integrative medicine consultation in Israel.

Authors:  Limor Almog; Efraim Lev; Elad Schiff; Shai Linn; Eran Ben-Arye
Journal:  Support Care Cancer       Date:  2014-05-10       Impact factor: 3.603

10.  Impact of a complementary/integrative medicine program on the need for supportive cancer care-related medications.

Authors:  Ilanit Shalom-Sharabi; Noah Samuels; Efraim Lev; Ofer Lavie; Lital Keinan-Boker; Elad Schiff; Eran Ben-Arye
Journal:  Support Care Cancer       Date:  2017-04-22       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.